Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis

Background: Survival in frontotemporal dementia (FTD) is not well understood. We conducted a mixed effects meta-analysis of survival in FTD to examine phenotype differences and contributory factors. Methods: The PubMed, Medline, EMBASE, CINAHL, PsycINFO and Cochrane databases were searched for studi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dementia and geriatric cognitive disorders 2016-03, Vol.41 (1-2), p.109-122
Hauptverfasser: Kansal, Kalyani, Mareddy, Manisha, Sloane, Kelly L., Minc, Alexa A., Rabins, Peter V., McGready, John B., Onyike, Chiadi U.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 122
container_issue 1-2
container_start_page 109
container_title Dementia and geriatric cognitive disorders
container_volume 41
creator Kansal, Kalyani
Mareddy, Manisha
Sloane, Kelly L.
Minc, Alexa A.
Rabins, Peter V.
McGready, John B.
Onyike, Chiadi U.
description Background: Survival in frontotemporal dementia (FTD) is not well understood. We conducted a mixed effects meta-analysis of survival in FTD to examine phenotype differences and contributory factors. Methods: The PubMed, Medline, EMBASE, CINAHL, PsycINFO and Cochrane databases were searched for studies describing survival or natural history of behavioral variant FTD (bvFTD), progressive non-fluent aphasia (PNFA), semantic dementia (SD), FTD with amyotrophic lateral sclerosis (FTD-ALS), progressive supranuclear palsy and corticobasal degeneration. There were no language restrictions. Results: We included 27 studies (2,462 subjects). Aggregate mean and median survival were derived for each phenotype and, for comparison, Alzheimer's disease (AD) (using data from the selected studies). Survival was shortest in FTD-ALS (2.5 years). Mean survival was longest in bvFTD and PNFA (8 years) and median survival in SD (12 years). AD was comparable in survival to all except FTD-ALS. Age and sex did not affect survival; the education effect was equivocal. Heterogeneity in FTD survival was largely, but not wholly, explained by phenotypes. Conclusions: Survival differs for FTD phenotypes but, except for FTD-ALS, compares well to AD survival. Elucidating the potential causes of within-phenotype heterogeneity in survival (such as complicating features and comorbidities) may open up opportunities for tailored interventions.
doi_str_mv 10.1159/000443205
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000443205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A599052653</galeid><sourcerecordid>A599052653</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-60a4e58596fdb7ad71ceb51e7c4876977db33dc4e6e414e1658fa68c6537077c3</originalsourceid><addsrcrecordid>eNpt0M9r2zAUB3AxVpa266H3MQyD0h28SbZ-7lJM0nSDlg3anoViPzfubMuV5ED--6pzmsHYSQ_x4X0fX4ROCf5CCFNfMcaU5hlmb9AhoRlJlczo2z8zTiXGcoaOvH-MTDCu3qFZxiWjMhOH6OJ2dJtmY9qk6ZOls32wAbrBuvizgA760Jjk1xp6G7YD-G9JkdxAMGnRm3brG_8eHdSm9XCye4_R_fLybv49vf559WNeXKclzWRIOTYUmGSK19VKmEqQElaMgCipFFwJUa3yvCopcKCEAuFM1obLkrNcYCHK_BidT3sHZ59G8EF3jS-hbU0PdvSaCE65UrmQkX76hz7a0cV7o5IEUy6EYFGdTerBtKDXYNqw9rYdQ2N7rwumFGZZjI_w8wRLZ713UOvBNZ1xW02wfqlf7-uP9uMuelx1UO3la99_b_tt3AO4PVhc3kwr9FDVUX34r9qlPAM2YpFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1810467775</pqid></control><display><type>article</type><title>Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis</title><source>MEDLINE</source><source>Karger Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Kansal, Kalyani ; Mareddy, Manisha ; Sloane, Kelly L. ; Minc, Alexa A. ; Rabins, Peter V. ; McGready, John B. ; Onyike, Chiadi U.</creator><creatorcontrib>Kansal, Kalyani ; Mareddy, Manisha ; Sloane, Kelly L. ; Minc, Alexa A. ; Rabins, Peter V. ; McGready, John B. ; Onyike, Chiadi U.</creatorcontrib><description>Background: Survival in frontotemporal dementia (FTD) is not well understood. We conducted a mixed effects meta-analysis of survival in FTD to examine phenotype differences and contributory factors. Methods: The PubMed, Medline, EMBASE, CINAHL, PsycINFO and Cochrane databases were searched for studies describing survival or natural history of behavioral variant FTD (bvFTD), progressive non-fluent aphasia (PNFA), semantic dementia (SD), FTD with amyotrophic lateral sclerosis (FTD-ALS), progressive supranuclear palsy and corticobasal degeneration. There were no language restrictions. Results: We included 27 studies (2,462 subjects). Aggregate mean and median survival were derived for each phenotype and, for comparison, Alzheimer's disease (AD) (using data from the selected studies). Survival was shortest in FTD-ALS (2.5 years). Mean survival was longest in bvFTD and PNFA (8 years) and median survival in SD (12 years). AD was comparable in survival to all except FTD-ALS. Age and sex did not affect survival; the education effect was equivocal. Heterogeneity in FTD survival was largely, but not wholly, explained by phenotypes. Conclusions: Survival differs for FTD phenotypes but, except for FTD-ALS, compares well to AD survival. Elucidating the potential causes of within-phenotype heterogeneity in survival (such as complicating features and comorbidities) may open up opportunities for tailored interventions.</description><identifier>ISSN: 1420-8008</identifier><identifier>EISSN: 1421-9824</identifier><identifier>DOI: 10.1159/000443205</identifier><identifier>PMID: 26854827</identifier><identifier>CODEN: DGCDFX</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Advertising executives ; Aged ; Alzheimer Disease - mortality ; Alzheimer's disease ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - mortality ; Aphasia ; Comorbidity ; Dementia ; Development and progression ; Epidemiology ; Female ; Frontotemporal Dementia - mortality ; Genetic aspects ; Health aspects ; Humans ; Life expectancy ; Male ; Movement disorders ; Neurodegenerative diseases ; Phenotype ; Phenotypes ; Primary Progressive Nonfluent Aphasia - mortality ; Progressive supranuclear palsy ; Review Article ; Supranuclear Palsy, Progressive - mortality ; Survival Rate ; Systematic review ; Wernicke's aphasia</subject><ispartof>Dementia and geriatric cognitive disorders, 2016-03, Vol.41 (1-2), p.109-122</ispartof><rights>2016 S. Karger AG, Basel</rights><rights>2016 S. Karger AG, Basel.</rights><rights>COPYRIGHT 2016 S. Karger AG</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-60a4e58596fdb7ad71ceb51e7c4876977db33dc4e6e414e1658fa68c6537077c3</citedby><cites>FETCH-LOGICAL-c428t-60a4e58596fdb7ad71ceb51e7c4876977db33dc4e6e414e1658fa68c6537077c3</cites><orcidid>0000-0003-2255-4437</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26854827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kansal, Kalyani</creatorcontrib><creatorcontrib>Mareddy, Manisha</creatorcontrib><creatorcontrib>Sloane, Kelly L.</creatorcontrib><creatorcontrib>Minc, Alexa A.</creatorcontrib><creatorcontrib>Rabins, Peter V.</creatorcontrib><creatorcontrib>McGready, John B.</creatorcontrib><creatorcontrib>Onyike, Chiadi U.</creatorcontrib><title>Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis</title><title>Dementia and geriatric cognitive disorders</title><addtitle>Dement Geriatr Cogn Disord</addtitle><description>Background: Survival in frontotemporal dementia (FTD) is not well understood. We conducted a mixed effects meta-analysis of survival in FTD to examine phenotype differences and contributory factors. Methods: The PubMed, Medline, EMBASE, CINAHL, PsycINFO and Cochrane databases were searched for studies describing survival or natural history of behavioral variant FTD (bvFTD), progressive non-fluent aphasia (PNFA), semantic dementia (SD), FTD with amyotrophic lateral sclerosis (FTD-ALS), progressive supranuclear palsy and corticobasal degeneration. There were no language restrictions. Results: We included 27 studies (2,462 subjects). Aggregate mean and median survival were derived for each phenotype and, for comparison, Alzheimer's disease (AD) (using data from the selected studies). Survival was shortest in FTD-ALS (2.5 years). Mean survival was longest in bvFTD and PNFA (8 years) and median survival in SD (12 years). AD was comparable in survival to all except FTD-ALS. Age and sex did not affect survival; the education effect was equivocal. Heterogeneity in FTD survival was largely, but not wholly, explained by phenotypes. Conclusions: Survival differs for FTD phenotypes but, except for FTD-ALS, compares well to AD survival. Elucidating the potential causes of within-phenotype heterogeneity in survival (such as complicating features and comorbidities) may open up opportunities for tailored interventions.</description><subject>Advertising executives</subject><subject>Aged</subject><subject>Alzheimer Disease - mortality</subject><subject>Alzheimer's disease</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - mortality</subject><subject>Aphasia</subject><subject>Comorbidity</subject><subject>Dementia</subject><subject>Development and progression</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Frontotemporal Dementia - mortality</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Life expectancy</subject><subject>Male</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Primary Progressive Nonfluent Aphasia - mortality</subject><subject>Progressive supranuclear palsy</subject><subject>Review Article</subject><subject>Supranuclear Palsy, Progressive - mortality</subject><subject>Survival Rate</subject><subject>Systematic review</subject><subject>Wernicke's aphasia</subject><issn>1420-8008</issn><issn>1421-9824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0M9r2zAUB3AxVpa266H3MQyD0h28SbZ-7lJM0nSDlg3anoViPzfubMuV5ED--6pzmsHYSQ_x4X0fX4ROCf5CCFNfMcaU5hlmb9AhoRlJlczo2z8zTiXGcoaOvH-MTDCu3qFZxiWjMhOH6OJ2dJtmY9qk6ZOls32wAbrBuvizgA760Jjk1xp6G7YD-G9JkdxAMGnRm3brG_8eHdSm9XCye4_R_fLybv49vf559WNeXKclzWRIOTYUmGSK19VKmEqQElaMgCipFFwJUa3yvCopcKCEAuFM1obLkrNcYCHK_BidT3sHZ59G8EF3jS-hbU0PdvSaCE65UrmQkX76hz7a0cV7o5IEUy6EYFGdTerBtKDXYNqw9rYdQ2N7rwumFGZZjI_w8wRLZ713UOvBNZ1xW02wfqlf7-uP9uMuelx1UO3la99_b_tt3AO4PVhc3kwr9FDVUX34r9qlPAM2YpFY</recordid><startdate>20160301</startdate><enddate>20160301</enddate><creator>Kansal, Kalyani</creator><creator>Mareddy, Manisha</creator><creator>Sloane, Kelly L.</creator><creator>Minc, Alexa A.</creator><creator>Rabins, Peter V.</creator><creator>McGready, John B.</creator><creator>Onyike, Chiadi U.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2255-4437</orcidid></search><sort><creationdate>20160301</creationdate><title>Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis</title><author>Kansal, Kalyani ; Mareddy, Manisha ; Sloane, Kelly L. ; Minc, Alexa A. ; Rabins, Peter V. ; McGready, John B. ; Onyike, Chiadi U.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-60a4e58596fdb7ad71ceb51e7c4876977db33dc4e6e414e1658fa68c6537077c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Advertising executives</topic><topic>Aged</topic><topic>Alzheimer Disease - mortality</topic><topic>Alzheimer's disease</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - mortality</topic><topic>Aphasia</topic><topic>Comorbidity</topic><topic>Dementia</topic><topic>Development and progression</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Frontotemporal Dementia - mortality</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Life expectancy</topic><topic>Male</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Primary Progressive Nonfluent Aphasia - mortality</topic><topic>Progressive supranuclear palsy</topic><topic>Review Article</topic><topic>Supranuclear Palsy, Progressive - mortality</topic><topic>Survival Rate</topic><topic>Systematic review</topic><topic>Wernicke's aphasia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kansal, Kalyani</creatorcontrib><creatorcontrib>Mareddy, Manisha</creatorcontrib><creatorcontrib>Sloane, Kelly L.</creatorcontrib><creatorcontrib>Minc, Alexa A.</creatorcontrib><creatorcontrib>Rabins, Peter V.</creatorcontrib><creatorcontrib>McGready, John B.</creatorcontrib><creatorcontrib>Onyike, Chiadi U.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Dementia and geriatric cognitive disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kansal, Kalyani</au><au>Mareddy, Manisha</au><au>Sloane, Kelly L.</au><au>Minc, Alexa A.</au><au>Rabins, Peter V.</au><au>McGready, John B.</au><au>Onyike, Chiadi U.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis</atitle><jtitle>Dementia and geriatric cognitive disorders</jtitle><addtitle>Dement Geriatr Cogn Disord</addtitle><date>2016-03-01</date><risdate>2016</risdate><volume>41</volume><issue>1-2</issue><spage>109</spage><epage>122</epage><pages>109-122</pages><issn>1420-8008</issn><eissn>1421-9824</eissn><coden>DGCDFX</coden><abstract>Background: Survival in frontotemporal dementia (FTD) is not well understood. We conducted a mixed effects meta-analysis of survival in FTD to examine phenotype differences and contributory factors. Methods: The PubMed, Medline, EMBASE, CINAHL, PsycINFO and Cochrane databases were searched for studies describing survival or natural history of behavioral variant FTD (bvFTD), progressive non-fluent aphasia (PNFA), semantic dementia (SD), FTD with amyotrophic lateral sclerosis (FTD-ALS), progressive supranuclear palsy and corticobasal degeneration. There were no language restrictions. Results: We included 27 studies (2,462 subjects). Aggregate mean and median survival were derived for each phenotype and, for comparison, Alzheimer's disease (AD) (using data from the selected studies). Survival was shortest in FTD-ALS (2.5 years). Mean survival was longest in bvFTD and PNFA (8 years) and median survival in SD (12 years). AD was comparable in survival to all except FTD-ALS. Age and sex did not affect survival; the education effect was equivocal. Heterogeneity in FTD survival was largely, but not wholly, explained by phenotypes. Conclusions: Survival differs for FTD phenotypes but, except for FTD-ALS, compares well to AD survival. Elucidating the potential causes of within-phenotype heterogeneity in survival (such as complicating features and comorbidities) may open up opportunities for tailored interventions.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>26854827</pmid><doi>10.1159/000443205</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2255-4437</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-8008
ispartof Dementia and geriatric cognitive disorders, 2016-03, Vol.41 (1-2), p.109-122
issn 1420-8008
1421-9824
language eng
recordid cdi_crossref_primary_10_1159_000443205
source MEDLINE; Karger Journals Complete; Alma/SFX Local Collection
subjects Advertising executives
Aged
Alzheimer Disease - mortality
Alzheimer's disease
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - mortality
Aphasia
Comorbidity
Dementia
Development and progression
Epidemiology
Female
Frontotemporal Dementia - mortality
Genetic aspects
Health aspects
Humans
Life expectancy
Male
Movement disorders
Neurodegenerative diseases
Phenotype
Phenotypes
Primary Progressive Nonfluent Aphasia - mortality
Progressive supranuclear palsy
Review Article
Supranuclear Palsy, Progressive - mortality
Survival Rate
Systematic review
Wernicke's aphasia
title Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A55%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20in%20Frontotemporal%20Dementia%20Phenotypes:%20A%20Meta-Analysis&rft.jtitle=Dementia%20and%20geriatric%20cognitive%20disorders&rft.au=Kansal,%20Kalyani&rft.date=2016-03-01&rft.volume=41&rft.issue=1-2&rft.spage=109&rft.epage=122&rft.pages=109-122&rft.issn=1420-8008&rft.eissn=1421-9824&rft.coden=DGCDFX&rft_id=info:doi/10.1159/000443205&rft_dat=%3Cgale_cross%3EA599052653%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1810467775&rft_id=info:pmid/26854827&rft_galeid=A599052653&rfr_iscdi=true